You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

Article metrics

Article menu

Download PDFPDF

Review
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

 

Online download statistics by month:

Online download statistics by month: January 2022 to March 2024

AbstractFullPdf
Jan 202225826352
Feb 2022327330139
Mar 202216517281
Apr 202215916764
May 202216417976
Jun 202213514080
Jul 202212412566
Aug 202214014157
Sep 202213113576
Oct 202213614073
Nov 2022838339
Dec 2022808038
Jan 2023707044
Feb 2023899047
Mar 2023636644
Apr 2023606027
May 2023484837
Jun 2023828224
Jul 2023616235
Aug 2023727230
Sep 2023575725
Oct 2023515139
Nov 2023596028
Dec 2023707135
Jan 2024474729
Feb 2024656727
Mar 2024868887
Total288229461399